497 related articles for article (PubMed ID: 21648198)
1. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
[TBL] [Abstract][Full Text] [Related]
2. Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms.
Tiţa B; Fuliaş A; Bandur G; Marian E; Tiţa D
J Pharm Biomed Anal; 2011 Sep; 56(2):221-7. PubMed ID: 21665404
[TBL] [Abstract][Full Text] [Related]
3. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
4. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
Desai D; Kothari S; Huang M
Int J Pharm; 2008 Apr; 354(1-2):77-81. PubMed ID: 18194844
[TBL] [Abstract][Full Text] [Related]
5. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
6. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
[TBL] [Abstract][Full Text] [Related]
7. Influence of compacted hydrophobic and hydrophilic colloidal silicon dioxide on tableting properties of pharmaceutical excipients.
Jonat S; Hasenzahl S; Gray A; Schmidt PC
Drug Dev Ind Pharm; 2005 Aug; 31(7):687-96. PubMed ID: 16207616
[TBL] [Abstract][Full Text] [Related]
8. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
9. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Guzmán HR; Tawa M; Zhang Z; Ratanabanangkoon P; Shaw P; Gardner CR; Chen H; Moreau JP; Almarsson O; Remenar JF
J Pharm Sci; 2007 Oct; 96(10):2686-702. PubMed ID: 17518357
[TBL] [Abstract][Full Text] [Related]
10. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
Puri V; Dantuluri AK; Bansal AK
J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
[TBL] [Abstract][Full Text] [Related]
11. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
[TBL] [Abstract][Full Text] [Related]
12. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersion dosage form.
Puri V; Dantuluri AK; Bansal AK
J Pharm Sci; 2012 Jan; 101(1):342-53. PubMed ID: 21935949
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.
Lakshmi K; Reddy MP; Kaza R
Curr Drug Discov Technol; 2013 Dec; 10(4):305-14. PubMed ID: 24074306
[TBL] [Abstract][Full Text] [Related]
14. Compatibility study between acetylcysteine and some commonly used tablet excipients.
Kerc J; Srcic S; Urleb U; Kanalec A; Kofler B; Smid-Korbar J
J Pharm Pharmacol; 1992 Jun; 44(6):515-8. PubMed ID: 1359077
[TBL] [Abstract][Full Text] [Related]
15. Compatibility studies of nateglinide with excipients in immediate release tablets.
Pani NR; Nath LK; Acharya S
Acta Pharm; 2011 Jun; 61(2):237-47. PubMed ID: 21684850
[TBL] [Abstract][Full Text] [Related]
16. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
[TBL] [Abstract][Full Text] [Related]
17. Investigating critical effects of variegated lubricants, glidants and hydrophilic additives on lag time of press coated ethylcellulose tablets.
Patadia R; Vora C; Mittal K; Mashru R
Pharm Dev Technol; 2016; 21(3):302-10. PubMed ID: 25566928
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
19. IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.
Meka VS; Yee P; Sheshala R
Acta Pol Pharm; 2016; 73(2):469-78. PubMed ID: 27180440
[TBL] [Abstract][Full Text] [Related]
20. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
